Furthermore, SIL A was shown to decrease lipotoxicity by attenuating oxidative stress and NFκB activation in nonalcoholic steatohepatitis (NASH) [7, 8]. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.